GMV 0.00% 3.9¢ g medical innovations holdings limited

Really solid 4C - the cash receipts were slightly lower than I...

  1. 1,595 Posts.
    lightbulb Created with Sketch. 1801
    Really solid 4C - the cash receipts were slightly lower than I expected ($1,478K versus my estimate of $1,600K), but the expenses were way down on my estimates ($2,388K versus estimate of $3,400K).

    The last 4 x cash outgoings (total expenses) on the 4C's have been approximately:

    31/12/18 $4,056k
    31/3/19 $3,635k
    30/6/19 $3,555K
    30/9/19 $2,388k

    There was a huge decrease in cash outgoings in the last quarter - so they are obviously "tightening their belts" due to the delay in the approvals.

    Cash burn of less than $1.0m this quarter (when it has always been from $2.2m to $2.7m) - reducing the nett cash outgoings will help a lot going forward.

    @ JG22 - surely you jest about complaining to the ASX? The 4C was on time!!, and I am sure we will get an update on the US & UK markets at some point.

    IMO GMV management really need some "clean air" now to finalise some deals, and make sure we get the approvals required ASAP.

    Am quietly confident that the market will like this 4C.
    Last edited by Brett M H: 31/10/19
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.